Broker Name: Lim & Tan Securities
Date of Report: 27 November 2025
Excerpt from Lim & Tan Securities report.
- The US and global equity markets showed positive momentum, bolstered by expectations of a US Federal Reserve rate cut in December, while Singapore’s FSSTI index remained strong with an 18.8% year-to-date gain.
- Coliwoo Holdings delivered robust core profitability in FY2025, with a 62.6% rise in core PATMI to S\$22.9 million, supported by high occupancy and strategic portfolio growth in Singapore’s co-living sector; the company is on track to expand to nearly 4,000 rooms by 2026 and is rated “Accumulate on Weakness.”
- Vicplas International’s medical devices segment (Forefront) benefits from high customer “stickiness” and long product lifecycles, but its overall profitability is challenged by start-up costs at new plants; there is currently no analyst coverage.
- China’s solar industry faces overcapacity and declining margins, with a near-term demand drop expected after policy-driven installations slow, but longer-term government support for renewables remains intact.
- Recent institutional flows in Singapore saw net selling, while retail investors were net buyers; top institutional buys included Keppel and Hongkong Land, while retail buying focused on DBS and Sembcorp Industries.
- Numerous share buybacks and insider transactions were reported across major Singapore-listed companies, and several companies announced upcoming dividend distributions.
Above is an excerpt from a report by Lim & Tan Securities. Clients of Lim & Tan Securities can be the first to access the full report from the Lim & Tan Securities website: https://www.limtan.com.sg
